IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Glaxosmithkline

CUSIP: 0925288 | 2 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Boston Common Asset Management, LLC37,160
0.0% of portfolio›$793
StyleTurnoverLocationFiled
Boston Common Asset Management, LLC
37,160$7930.0%CoreLowBoston, MA2016-11-04